GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Dividends per Share

Aroa Biosurgery (ASX:ARX) Dividends per Share : A$0.00 (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Dividends per Share?

Aroa Biosurgery's dividends per share for the six months ended in Mar. 2024 was A$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was A$0.00. Its Dividend Payout Ratio for the six months ended in Mar. 2024 was 0.00. As of today, Aroa Biosurgery's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


Aroa Biosurgery Dividends per Share Historical Data

The historical data trend for Aroa Biosurgery's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Dividends per Share Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Dividends per Share
- - - - -

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Dividends per Share Get a 7-Day Free Trial - - - - -

Competitive Comparison of Aroa Biosurgery's Dividends per Share

For the Medical Devices subindustry, Aroa Biosurgery's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aroa Biosurgery's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's Dividend Yield % falls into.



Aroa Biosurgery Dividends per Share Calculation

Dividends paid to per common share.


Aroa Biosurgery  (ASX:ARX) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Aroa Biosurgery's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ -0.011
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aroa Biosurgery Dividends per Share Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines